Artery Research
Volume 3, Issue 1 , Pages 39-42 , February 2009

H. pylori-induced higher C-reactive protein in obese African Americans

  • Nuzhat R. Siddiqui

      Affiliations

    • Department of Nutrition Sciences, University of Alabama at Birmingham, 1675 University Boulevard, Birmingham, AL 35294, USA
    • ,
  • W. Timothy Garvey

      Affiliations

    • Department of Nutrition Sciences, University of Alabama at Birmingham, 1675 University Boulevard, Birmingham, AL 35294, USA
    • The Birmingham Veterans Affairs Medical Center, Birmingham, AL 35233, USA
    • ,
  • Mohammad A. Khaled

      Affiliations

    • Department of Nutrition Sciences, University of Alabama at Birmingham, 1675 University Boulevard, Birmingham, AL 35294, USA
    • Corresponding Author InformationCorresponding author.

Received 23 September 2008 ,Revised 10 December 2008 ,Accepted 19 January 2009.

References 

  1. Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999;340:115–126
  2. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation. 1997;96:4095–4103
  3. Hocker M, Hohenberger P. Helicobacter pylori virulence factors-one part of a big picture. Lancet. 2003;362:1231–1233
  4. Graham DY, Adam E, Reddy GT, Agarwal JP, Agarwal R, Evans DJ, et al. Seroepidemiology of H. pylori infection in India: comparison of developing and developed countries. Dig Dis Sci. 1991;36:1084–1088
  5. Singh RK, McMohan AD, Patel H, Packard CJ, Rathbone BJ, Samani NJ. Prospective analysis of the association of infection with cagA bearing strains of Helicobacter pylori and coronary heart disease. Heart. 2002;88:43–46
  6. Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL, et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation. 1998;97:1675–1679
  7. Farmer JA, Torre-Amione G. Atherosclerosis and inflammation. Curr Atheroscler Rep. 2002;4:92–98
  8. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997;277:1775–1781
  9. Khaled MA, Cornwell PE. Hyperhomocysteinemia due to H. pylori. Atherosclerosis. 2004;172:199–200
  10. Schreiner PJ, Wu KK, Malinow MR, Stinson VL, Szklo M, Nieto FJ, et al. Hyperhomocyst(e)inemia and homeostatic factors: the atherosclerosis risk in community studies. Ann Epidemiol. 2002;12:228–236
  11. Abu-Mahfuz MZ, Prasad VM, Santogade P, Cutler AF. H. pylori recurrence after successful eradication: 5-year follow-up in the United States. Am J Gastroenterol. 1997;92:2025–2028
  12. Roe DA. Drug and nutrient interactions. In:  Bodwell CE,  Erdman JW editor. Nutrient interactions Ift Basic Symposium Series. New York: Marcel Dekker; 1988;p. 365–377
  13. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103:1813–1818
  14. Aronson D, Bartha P, Zinder O, Kerner A, Markiewicz W, Avizohar O, et al. Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obesity. 2004;28:674–679
  15. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ. 1998;316:1130–1132
  16. Wolf SC, Brehm BR, Mayer O, Jürgens S, Schultze G. Risler T Infectious risk for atherosclerotic vascular disease in hemodialysis patients – Chlamydia pneumoniae but not Helicobacter pylori or cytomegalovirus is associated with increased C-reactive protein. Ren Fail. 2004;26:279–287
  17. Kanbay M, Kasapoglu B, Turgut F, Uz E, Bavbek N, Akcay A. Helicobacter pylori: a major risk factor for endothelial dysfunction. Med Hypotheses. 2007;69:227–228
  18. Lip GH, Wise R, Beevers G. Association of Helicobacter pylori with coronary heart disease. BMJ. 1996;312:250–251
  19. Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ. 1997;315:1199–1201

PII: S1872-9312(09)00005-2

doi: 10.1016/j.artres.2009.01.004

Artery Research
Volume 3, Issue 1 , Pages 39-42 , February 2009

Article Tools

* Image Usage & Resolution